PremiumThe FlyAllogene Therapeutics appoints Douglas as General Counsel AMTI Upcoming Earnings Report: What to Expect? Is AMTI a Buy, Before Earnings? PremiumThe FlyApplied Molecular Transport presents additional data from FILLMORE trial Applied Molecular Transport downgraded to Underperform from Hold at Jefferies BofA double downgrades Applied Molecular with upside catalysts removed PremiumThe FlyApplied Molecular Transport downgraded to Market Perform from Outperform at JMP Securities Applied Molecular Transport downgraded to Market Perform at JMP Securities Applied Molecular Transport announces phase 2 results from Oral AMT-101 trial 
